• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环丙沙星和哌拉西林在梗阻性胆道中的胆汁排泄。

Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract.

作者信息

van den Hazel S J, de Vries X H, Speelman P, Dankert J, Tytgat G N, Huibregtse K, van Leeuwen D J

机构信息

Department of Gastroenterology and Hepatology, University of Amsterdam, The Netherlands.

出版信息

Antimicrob Agents Chemother. 1996 Nov;40(11):2658-60. doi: 10.1128/AAC.40.11.2658.

DOI:10.1128/AAC.40.11.2658
PMID:8913485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC163596/
Abstract

Biliary excretion of ciprofloxacin and piperacillin was determined in cholestatic patients who had undergone endoscopic cholangiography. The median concentration of ciprofloxacin (n = 9) was 2.36 micrograms/ml (range, 0.29 to 19.8 micrograms/ml) in bile compared with 1.66 micrograms/ml (range, 0.73 to 2.69 micrograms/ml) in serum. The median concentration of piperacillin (n = 7) was < 5 micrograms/ml (range, < 5 to 26) in bile compared with 14.3 micrograms/ml (range, 5.3 to 80) in serum. Ciprofloxacin, but not piperacillin, can be actively excreted into bile in the presence of a biliary tract obstruction.

摘要

在接受内镜胆管造影的胆汁淤积患者中测定了环丙沙星和哌拉西林的胆汁排泄情况。环丙沙星(n = 9)在胆汁中的中位浓度为2.36微克/毫升(范围为0.29至19.8微克/毫升),而在血清中的中位浓度为1.66微克/毫升(范围为0.73至2.69微克/毫升)。哌拉西林(n = 7)在胆汁中的中位浓度<5微克/毫升(范围为<5至26),而在血清中的中位浓度为14.3微克/毫升(范围为5.3至80)。在存在胆道梗阻的情况下,环丙沙星可被主动排泄到胆汁中,而哌拉西林则不能。

相似文献

1
Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract.环丙沙星和哌拉西林在梗阻性胆道中的胆汁排泄。
Antimicrob Agents Chemother. 1996 Nov;40(11):2658-60. doi: 10.1128/AAC.40.11.2658.
2
Experimental studies of biliary excretion of piperacillin.哌拉西林胆汁排泄的实验研究。
Ann Surg. 1987 Apr;205(4):420-7. doi: 10.1097/00000658-198704000-00013.
3
Pharmacodynamic interactions of ciprofloxacin, piperacillin, and piperacillin/tazobactam in healthy volunteers.环丙沙星、哌拉西林及哌拉西林/他唑巴坦在健康志愿者中的药效学相互作用
J Clin Pharmacol. 1998 Nov;38(11):1063-71. doi: 10.1177/009127009803801112.
4
The effects of bile duct obstruction on the biliary secretion of ciprofloxacin in piglets.
Am J Gastroenterol. 1999 Sep;94(9):2408-11. doi: 10.1111/j.1572-0241.1999.01365.x.
5
Assessment of biliary excretion of piperacillin-tazobactam in humans.哌拉西林-他唑巴坦在人体中的胆汁排泄评估。
Antimicrob Agents Chemother. 1997 Aug;41(8):1636-40. doi: 10.1128/AAC.41.8.1636.
6
The pharmacokinetics of the biliary excretion of ciprofloxacin.环丙沙星胆汁排泄的药代动力学。
HPB Surg. 1989 Nov;1(4):319-26; discussion 326-7. doi: 10.1155/1989/41415.
7
Penetration of ciprofloxacin and fleroxacin into biliary tract.环丙沙星和氟罗沙星在胆道中的渗透性。
Antimicrob Agents Chemother. 1996 Mar;40(3):787-91. doi: 10.1128/AAC.40.3.787.
8
Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime.胆管梗阻对环丙沙星和头孢噻肟渗透的影响。
Eur J Gastroenterol Hepatol. 2008 Feb;20(2):127-30. doi: 10.1097/MEG.0b013e3282f1c985.
9
[Excretion of antibiotics into bile and urine in patients with external cholecystostomy done in order to treat obstructive jaundice].[为治疗梗阻性黄疸而行体外胆囊造瘘术患者抗生素在胆汁和尿液中的排泄情况]
Jpn J Antibiot. 1988 Sep;41(9):1295-303.
10
Biliary excretion of piperacillin.哌拉西林的胆汁排泄。
J Int Med Res. 1983;11(1):28-31. doi: 10.1177/030006058301100106.

引用本文的文献

1
Population Pharmacokinetics and Dose Optimization of Piperacillin in Infants and Children with Pneumonia.哌拉西林在婴幼儿肺炎患者中的群体药代动力学及剂量优化
Paediatr Drugs. 2025 Jan;27(1):91-102. doi: 10.1007/s40272-024-00664-4. Epub 2024 Nov 27.
2
Isolated microorganisms in plastic biliary stents placed for benign and malignant diseases.放置于良性和恶性疾病患者体内的塑料胆管支架中的分离微生物。
Ann Gastroenterol. 2014;27(4):399-403.
3
2013 WSES guidelines for management of intra-abdominal infections.2013 WSES 腹腔内感染管理指南。
World J Emerg Surg. 2013 Jan 8;8(1):3. doi: 10.1186/1749-7922-8-3.
4
Antimicrobial management of intra-abdominal infections: literature's guidelines.腹腔内感染的抗菌管理:文献指南。
World J Gastroenterol. 2012 Mar 7;18(9):865-71. doi: 10.3748/wjg.v18.i9.865.
5
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.WSES 共识会议:腹腔内感染一线治疗管理指南。
World J Emerg Surg. 2011 Jan 13;6:2. doi: 10.1186/1749-7922-6-2.
6
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.肝功能不全患者的药代动力学及剂量调整
Eur J Clin Pharmacol. 2008 Dec;64(12):1147-61. doi: 10.1007/s00228-008-0553-z. Epub 2008 Sep 2.
7
In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis.莫西沙星和哌拉西林/舒巴坦对急性胆管炎病原体的体外活性。
World J Gastroenterol. 2008 May 28;14(20):3174-8. doi: 10.3748/wjg.14.3174.
8
Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.急性胆管炎的抗菌治疗:东京指南
J Hepatobiliary Pancreat Surg. 2007;14(1):59-67. doi: 10.1007/s00534-006-1157-6. Epub 2007 Jan 30.
9
Biliary tract infections: a guide to drug treatment.胆道感染:药物治疗指南
Drugs. 1999 Jan;57(1):81-91. doi: 10.2165/00003495-199957010-00007.

本文引用的文献

1
HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids.体液中环丙沙星及其代谢产物的高效液相色谱分析。
J Pharm Biomed Anal. 1995 Dec;14(1-2):181-90. doi: 10.1016/0731-7085(95)01611-2.
2
Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers.人肠上皮Caco-2细胞层对氟喹诺酮类药物环丙沙星的主动分泌。
Br J Pharmacol. 1993 Mar;108(3):575-6. doi: 10.1111/j.1476-5381.1993.tb12844.x.
3
The intestinal elimination of ciprofloxacin in the rat.
J Infect Dis. 1994 Jan;169(1):218-21. doi: 10.1093/infdis/169.1.218.
4
Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?氟喹诺酮类抗菌药物环丙沙星、诺氟沙星和培氟沙星的肠道主动分泌;存在共同的分泌途径吗?
J Pharmacol Exp Ther. 1994 May;269(2):496-502.
5
Biliary excretion of ceftriaxone into non-stagnant and stagnant bile.
J Antimicrob Chemother. 1994 Jan;33(1):193-4. doi: 10.1093/jac/33.1.193.
6
Antibiotics, biliary sepsis, and bile duct stones.抗生素、胆源性脓毒症和胆管结石。
Gastrointest Endosc. 1994 Nov-Dec;40(6):716-21.
7
The role of the canalicular multispecific organic anion transporter in the disposal of endo- and xenobiotics.
Pharmacol Ther. 1994 Oct;64(1):77-97. doi: 10.1016/0163-7258(94)90034-5.
8
Biliary excretion of aztreonam in patients with biliary tract disease.氨曲南在胆道疾病患者中的胆汁排泄情况。
Antimicrob Agents Chemother. 1984 Mar;25(3):358-61. doi: 10.1128/AAC.25.3.358.
9
Decreased biliary excretion of cefamandole after percutaneous biliary decompression in patients with total common bile duct obstruction.在胆总管完全梗阻患者经皮胆道减压后,头孢孟多的胆汁排泄减少。
Antimicrob Agents Chemother. 1984 Dec;26(6):944-6. doi: 10.1128/AAC.26.6.944.
10
Biliary excretion of piperacillin.哌拉西林的胆汁排泄。
J Int Med Res. 1983;11(1):28-31. doi: 10.1177/030006058301100106.